Earnings Call · Q2 FY2022·2022-08-02

Q2 22EPS +29.41%·Rev n/aQ1 22EPS +18.75%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS -20.00%·Rev n/a⚠ consensus missing

Nautilus Biotechnology, Inc. NAUT

Unidentified Company Representative — Investor Relations or Corporate Communications Representative

Sujal Patel — Chief Executive Officer

Anna Mowry — Chief Financial Officer

−1.4%1d on move date−0.7% vs SPY3d−1.4%5d+1.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAUT calls or request research access.

More NAUT calls Browse calls Request research access